Waterloo Capital L.P. Has $2.54 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Waterloo Capital L.P. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,865 shares of the medical equipment provider’s stock after purchasing an additional 506 shares during the period. Waterloo Capital L.P.’s holdings in Intuitive Surgical were worth $2,539,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of ISRG. Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Intuitive Surgical by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after acquiring an additional 243,802 shares during the last quarter. Fisher Asset Management LLC boosted its holdings in Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after acquiring an additional 86,488 shares during the last quarter. Norges Bank bought a new position in Intuitive Surgical during the 4th quarter worth approximately $2,401,493,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Intuitive Surgical by 4.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,317,669 shares of the medical equipment provider’s stock worth $1,209,731,000 after purchasing an additional 90,202 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

ISRG stock opened at $451.58 on Friday. The business has a 50-day simple moving average of $545.18 and a two-hundred day simple moving average of $532.64. The company has a market capitalization of $160.84 billion, a P/E ratio of 70.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Analysts Set New Price Targets

Several research firms have recently weighed in on ISRG. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $611.86.

Insider Activity

In related news, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.